Complete Filing Data
CNS Pharmaceuticals, Inc. reported Stockholders Equity of $4.52 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean CNS Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$15.9M | -$14.9M | -$18.9M | -$15.3M | -$14.5M | -$9.5M | -$3.9M | -$7.4M |
| Research And Development Expense | $9.8M | $9.3M | $14.1M | $9.3M | $9.8M | $5.1M | $1.9M | $21.3K |
| Operating Income Loss | -$16.0M | -$14.9M | -$18.9M | -$15.3M | -$14.5M | -$9.5M | -$3.8M | -$881.8K |
| Operating Expenses | $16.0M | $14.9M | $18.9M | $15.3M | $14.5M | $9.5M | $3.8M | $881.8K |
| General And Administrative Expense | $6.2M | $5.6M | $4.8M | $6.0M | $4.7M | $4.4M | $2.0M | $860.5K |
| Nonoperating Income Expense | $136.0K | $44.1K | $13.9K | -$7.0K | -$9.3K | -$3.3K | -$44.2K | -$6.5M |
| Interest Expense | $13.8K | $7.0K | $9.3K | $3.3K | $26.2K | $28.6K | ||
| Income Taxes Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Nonoperating Income | $153.8K | $60.3K | $27.7K | |||||
| Interest Expense Nonoperating | $15.2K | $16.1K | $13.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$3.2M | -$2.4M | -$4.3M | -$5.6M | -$2.5M | -$3.5M | -$4.5M | -$4.0M | -$4.9M | -$3.4M | -$3.6M | -$3.2M | -$3.8M | -$3.8M | -$3.6M | -$2.0M | -$2.5M | -$2.0M | -$706.7K | -$431.7K | -$211.5K | -$193.2K | -$257.5K | -$309.7K |
| Research And Development Expense | $2.2M | $1.2M | $3.2M | $4.2M | $1.1M | $2.4M | $3.4M | $2.8M | $3.6M | $2.2M | $2.2M | $1.9M | $2.6M | $2.7M | $2.2M | $1.0M | $1.5M | $613.1K | $325.6K | $42.7K | $48.3K | $4.6K | ||
| Operating Income Loss | -$3.3M | -$2.4M | -$4.3M | -$5.6M | -$2.5M | -$3.5M | -$4.5M | -$4.0M | -$4.9M | -$3.4M | -$3.6M | -$3.1M | -$3.8M | -$3.8M | -$3.6M | -$2.0M | -$2.5M | -$2.0M | -$699.1K | -$415.1K | -$195.1K | -$169.9K | ||
| Operating Expenses | $3.3M | $2.4M | $4.3M | $5.6M | $2.5M | $3.5M | $4.5M | $4.0M | $4.9M | $3.4M | $3.6M | $3.1M | $3.8M | $3.8M | $3.6M | $2.0M | $2.5M | $2.0M | $699.1K | $415.1K | $195.1K | $169.9K | ||
| General And Administrative Expense | $1.1M | $1.2M | $1.1M | $1.4M | $1.4M | $1.1M | $1.1M | $1.2M | $1.4M | $1.2M | $1.3M | $1.3M | $1.2M | $1.1M | $1.4M | $968.8K | $981.5K | $1.4M | $373.5K | $372.3K | $146.8K | $165.3K | ||
| Nonoperating Income Expense | $34.9K | $34.4K | $36.3K | $23.0K | -$2.6K | $106.00 | $11.0K | $4.2K | -$5.4K | -$538.00 | -$1.6K | -$2.6K | -$947.00 | -$2.4K | -$3.7K | $0.00 | $0.00 | $0.00 | -$7.6K | -$16.6K | ||||
| Interest Expense | $6.6K | $1.8K | $3.7K | $5.4K | $538.00 | $1.6K | $2.6K | $947.00 | $2.4K | $3.7K | $0.00 | $0.00 | $0.00 | $7.6K | $7.5K | $7.5K | $10.6K | |||||||
| Income Taxes Paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Other Nonoperating Income | $37.0K | $38.6K | $42.5K | $25.2K | $1.8K | $6.7K | $12.9K | $7.8K | ||||||||||||||||
| Interest Expense Nonoperating | $2.1K | $4.2K | $6.2K | $2.3K | $4.5K | $6.6K | $1.8K | $3.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $4.5M | $6.2M | -$4.4M | $8.1M | $6.2M | $13.9M | $7.6M | -$549.3K | -$58.5K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.2M | $6.5M | $548.7K | $10.1M | $5.0M | $14.0M | $7.2M | $555.1K | $110.5K |
| Cash And Cash Equivalents At Carrying Value | $7.2M | $6.5M | $548.7K | $10.1M | $5.0M | $14.0M | $7.2M | $282.7K | |
| Retained Earnings Accumulated Deficit | -$100.3M | -$84.4M | -$69.6M | -$50.7M | -$35.4M | -$20.9M | -$11.5M | -$7.6M | |
| Repayments Of Notes Payable | $297.6K | $300.8K | $438.7K | $427.7K | $477.5K | $43.1K | $35.0K | $0.00 | |
| Property Plant And Equipment Net | $17.7K | $6.0K | $4.9K | $5.7K | $16.1K | $23.4K | $18.2K | $0.00 | |
| Liabilities Current | $4.1M | $2.5M | $6.1M | $4.9M | $2.6M | $1.9M | $311.0K | $1.2M | |
| Liabilities And Stockholders Equity | $8.6M | $8.7M | $1.7M | $13.1M | $8.8M | $15.9M | $7.9M | $683.3K | |
| Liabilities | $4.1M | $2.5M | $6.1M | $4.9M | $2.6M | $1.9M | $311.0K | $1.2M | |
| Common Stock Value | $633.00 | $118.00 | $2.00 | $1.6K | $949.00 | $23.9K | $16.5K | $12.7K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $739.6K | $5.9M | -$9.5M | $5.1M | -$9.0M | $6.8M | $6.7M | $444.6K | |
| Assets Current | $8.1M | $8.7M | $1.6M | $12.6M | $7.5M | $15.5M | $7.9M | $588.1K | |
| Assets | $8.6M | $8.7M | $1.7M | $13.1M | $8.8M | $15.9M | $7.9M | $683.3K | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Notes Payable Current | $328.6K | $326.1K | $300.8K | $410.0K | $387.8K | $439.3K | $0.00 | $35.0K | |
| Assets Noncurrent | $520.7K | $42.4K | $109.7K | $488.5K | $1.3M | $357.6K | $18.2K | ||
| Deferred Offering Costs | $45.5K | $20.6K | $202.9K | $0.00 | $334.1K | $334.1K | $0.00 | ||
| Gain Loss On Disposition Of Assets | -$2.6K | $190.00 | -$498.00 | -$3.1K | $0.00 | -$1.6K | $0.00 | ||
| Accrued Liabilities Current | $224.9K | $519.8K | $21.5K | $23.6K | |||||
| Accounts Payable Current | $2.0M | $946.3K | $243.7K | $128.1K | |||||
| Prepaid Expense And Other Assets Current | $856.3K | $1.3M | $839.6K | $2.5M | $2.5M | ||||
| Accounts Payable And Accrued Liabilities Current | $3.8M | $2.2M | $5.8M | $4.5M | |||||
| Amortization Of Debt Discount Premium | $0.00 | $18.1K | $18.1K | ||||||
| Cashless Exercise Of Warrants | $0.00 | $1.8K | $0.00 | ||||||
| Reclassification Of Deferred Offering Costs To Equity | $39.2K | $249.0K | $0.00 | ||||||
| Accounts Payable Related Parties Current | $0.00 | $45.8K | $794.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $9.9M | $13.1M | $11.0M | $3.4M | -$4.3M | -$4.4M | -$1.7M | $2.5M | $3.5M | $7.6M | $10.7M | $14.0M | $9.1M | $12.4M | $11.2M | $2.5M | $3.7M | $5.9M | $216.00 | $377.7K | -$716.8K | -$347.0K | -$197.8K | $35.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $9.9M | $12.1M | $13.0M | $7.0M | $1.5M | $815.2K | $909.5K | $4.3M | $5.1M | $7.0M | $9.0M | $12.4M | $8.3M | $6.9M | $11.1M | $1.3M | $2.6M | $5.4M | $899.5K | $1.2M | $424.4K | $708.6K | |||
| Cash And Cash Equivalents At Carrying Value | $9.9M | $12.1M | $13.0M | $7.0M | $1.5M | $815.2K | $909.5K | $4.3M | $5.1M | $7.0M | $9.0M | $12.4M | $8.3M | $6.9M | $11.1M | $1.3M | $2.6M | $5.4M | $630.1K | $911.9K | $155.0K | ||||
| Retained Earnings Accumulated Deficit | -$94.3M | -$91.1M | -$88.7M | -$81.2M | -$75.6M | -$73.1M | -$64.2M | -$59.7M | -$55.6M | -$44.8M | -$41.3M | -$37.8M | -$32.2M | -$28.4M | -$24.6M | -$17.9M | -$15.9M | -$13.5M | -$9.0M | ||||||
| Repayments Of Notes Payable | $86.9K | $87.7K | $120.9K | $115.2K | $130.2K | $0.00 | $35.0K | ||||||||||||||||||
| Property Plant And Equipment Net | $3.1K | $3.8K | $4.9K | $2.8K | $3.6K | $4.3K | $3.5K | $3.4K | $4.4K | $8.5K | $11.0K | $12.7K | $17.5K | $20.9K | $24.1K | $28.2K | $31.3K | $22.7K | $7.5K | ||||||
| Liabilities Current | $2.0M | $1.4M | $2.8M | $4.1M | $6.8M | $6.1M | $4.1M | $4.0M | $3.9M | $1.2M | $923.9K | $1.1M | $2.4M | $1.8M | $1.9M | $510.8K | $261.2K | $336.0K | $1.4M | ||||||
| Liabilities And Stockholders Equity | $11.9M | $14.5M | $13.7M | $7.4M | $2.5M | $1.7M | $2.3M | $6.5M | $7.4M | $9.6M | $12.4M | $15.9M | $11.5M | $14.2M | $13.1M | $3.0M | $4.0M | $6.2M | $1.4M | ||||||
| Liabilities | $2.0M | $1.4M | $2.8M | $4.1M | $6.8M | $6.1M | $4.1M | $4.0M | $3.9M | $1.2M | $923.9K | $1.1M | $2.4M | $1.8M | $1.9M | $510.8K | $261.2K | $336.0K | $1.4M | ||||||
| Common Stock Value | $574.00 | $504.00 | $2.9K | $33.4K | $1.4K | $10.7K | $4.2K | $4.1K | $2.2K | $40.0K | $40.0K | $40.0K | $27.5K | $27.4K | $25.4K | $16.7K | $16.5K | $16.5K | $13.6K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $6.6M | $266.5K | -$4.9M | $7.4M | -$3.0M | -$1.9M | -$130.7K | ||||||||||||||||||
| Assets Current | $11.4M | $14.1M | $13.7M | $7.4M | $2.1M | $1.6M | $2.1M | $6.1M | $7.0M | $8.7M | $11.4M | $14.7M | $11.2M | $13.9M | $12.8M | $2.5M | $4.0M | $6.2M | $1.4M | ||||||
| Assets | $11.9M | $14.5M | $13.7M | $7.4M | $2.5M | $1.7M | $2.3M | $6.5M | $7.4M | $9.6M | $12.4M | $15.9M | $11.5M | $14.2M | $13.1M | $3.0M | $4.0M | $6.2M | $1.4M | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Notes Payable Current | $30.8K | $121.8K | $210.7K | $31.2K | $123.2K | $213.1K | $41.9K | $166.4K | $289.1K | $39.3K | $156.4K | $272.6K | $44.6K | $177.6K | $309.1K | $0.00 | |||||||||
| Assets Noncurrent | $477.5K | $370.1K | $27.3K | $21.2K | $323.9K | $59.6K | $266.2K | $380.6K | $442.5K | $937.6K | $1.0M | $1.1M | $351.7K | $355.0K | $358.2K | $469.1K | |||||||||
| Deferred Offering Costs | $43.7K | $14.2K | $20.6K | $26.9K | $16.8K | $0.00 | $334.1K | $334.1K | $334.1K | $334.1K | $334.1K | $334.1K | $440.9K | ||||||||||||
| Gain Loss On Disposition Of Assets | $0.00 | $190.00 | $0.00 | ||||||||||||||||||||||
| Accrued Liabilities Current | $260.1K | $853.2K | $828.4K | $200.0K | $276.6K | $307.0K | $901.2K | $760.7K | $534.9K | $260.6K | $110.7K | $144.8K | $46.1K | ||||||||||||
| Accounts Payable Current | $3.6M | $2.8M | $3.7M | $1.0M | $490.9K | $489.7K | $1.5M | $892.5K | $1.1M | $250.2K | $150.5K | $141.2K | $278.3K | ||||||||||||
| Prepaid Expense And Other Assets Current | $1.5M | $2.0M | $653.8K | $388.0K | $637.1K | $786.1K | $1.2M | $1.8M | $1.9M | ||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $1.9M | $1.3M | $2.6M | $4.0M | $6.6M | $5.9M | $4.0M | ||||||||||||||||||
| Amortization Of Debt Discount Premium | $0.00 | $0.00 | $0.00 | $0.00 | $9.2K | $8.9K | $12.7K | ||||||||||||||||||
| Cashless Exercise Of Warrants | $0.00 | $1.3K | $0.00 | ||||||||||||||||||||||
| Reclassification Of Deferred Offering Costs To Equity | $0.00 | $202.9K | $0.00 | ||||||||||||||||||||||
| Accounts Payable Related Parties Current | $0.00 | $0.00 | $50.0K | $10.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $187.7K | $839.0K | $1.0M | $1.2M | $1.7M | $1.3M | $477.1K | $110.2K |
| Net Cash Provided By Used In Operating Activities | -$13.8M | -$17.1M | -$14.1M | -$10.6M | -$13.5M | -$7.3M | -$3.6M | -$716.4K |
| Net Cash Provided By Used In Financing Activities | $14.6M | $23.0M | $4.6M | $15.6M | $4.5M | $14.1M | $10.3M | $1.2M |
| Proceeds From Issuance Of Common Stock | $14.0M | $23.4M | $2.3M | $16.0M | $4.7M | $10.3M | $390.5K | |
| Proceeds From Warrant Exercises | $3.6K | $21.3K | $3.0M | $2.7K | $332.8K | $0.00 | ||
| Net Cash Provided By Used In Investing Activities | -$18.2K | -$4.2K | -$3.9K | -$4.4K | -$5.7K | -$17.9K | -$20.1K | $0.00 |
| Payments To Acquire Property Plant And Equipment | $18.2K | $4.2K | $3.9K | $4.4K | $5.7K | $17.9K | $20.1K | $0.00 |
| Increase Decrease In Accrued Liabilities | $603.4K | -$294.9K | $498.3K | $40.4K | -$6.2K | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.5M | -$3.6M | $1.3M | $2.3M | ||||
| Stock Issued During Period Value Share Based Compensation | $1.2M | $1.7M | $1.3M | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$302.8K | $60.0K | -$2.4M | -$860.5K | ||||
| Increase Decrease In Prepaid Expense | $1.5M | $321.4K | $619.6K | -$18.7K | ||||
| Increase Decrease In Accounts Payable | $1.7M | $1.0M | $702.7K | $108.6K | $85.6K | |||
| Payments Of Debt Issuance Costs | $0.00 | $45.0K | $0.00 | $95.2K | ||||
| Increase Decrease In Accounts Payable Related Parties | $0.00 | -$45.8K | $45.0K | -$14.2K | ||||
| Payments For Repurchase Of Initial Public Offering | $64.1K | $66.8K | $202.9K | $0.00 | ||||
| Increase Decrease In Other Accounts Payable | $576.5K | $702.7K | ||||||
| Payments Of Stock Issuance Costs | $2.0K | $0.00 | $0.00 | $21.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $62.4K | $202.9K | $290.3K | $336.7K | $430.7K | $242.2K | $44.0K | ||||||
| Net Cash Provided By Used In Operating Activities | -$3.2M | -$3.2M | -$4.8M | -$3.1M | -$3.3M | -$1.9M | -$82.7K | ||||||
| Net Cash Provided By Used In Financing Activities | $9.8M | $3.5M | -$120.3K | $10.5M | $347.4K | $0.00 | -$48.0K | ||||||
| Proceeds From Issuance Of Common Stock | $3.5M | $0.00 | $10.6M | $144.8K | $0.00 | ||||||||
| Proceeds From Warrant Exercises | $0.00 | $12.4K | $609.00 | $2.6K | $332.8K | $0.00 | |||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | -$3.7K | -$6.4K | $0.00 | |||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $3.7K | $6.4K | $0.00 | |||||||||
| Increase Decrease In Accrued Liabilities | $24.8K | $82.1K | $15.1K | $123.3K | $4.7K | ||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $372.8K | $46.1K | -$876.5K | $4.2K | -$794.00 | ||||||||
| Stock Issued During Period Value Share Based Compensation | $290.3K | $289.7K | $286.8K | $336.7K | $506.6K | $469.6K | $430.7K | $365.0K | $323.2K | $242.2K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$623.2K | -$103.0K | -$692.2K | -$318.1K | |||||||||
| Increase Decrease In Prepaid Expense | -$318.1K | $122.2K | $156.1K | -$13.0K | |||||||||
| Increase Decrease In Accounts Payable | -$901.3K | -$665.7K | -$102.4K | $59.0K | |||||||||
| Payments Of Debt Issuance Costs | $0.00 | $13.0K | |||||||||||
| Increase Decrease In Accounts Payable Related Parties | $0.00 | $4.2K | |||||||||||
| Payments For Repurchase Of Initial Public Offering | |||||||||||||
| Increase Decrease In Other Accounts Payable | -$1.0M | $111.4K | -$102.4K | ||||||||||
| Payments Of Stock Issuance Costs | $557.00 | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$35.75 | -$466.89 | -$12.5K | -$11.22 | -$16.50 | -$0.57 | -$0.28 | -$0.70 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 75.0M | 75.0M | 75.0M | 75.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 632.5K | 117.8K | 2.5K | 1.6M | 949.1K | 23.9M | 16.5M | |
| Weighted Average Number Of Shares Outstanding Basic | 443.4K | 31.8K | 1.5K | 1.4M | 878.4K | |||
| Weighted Average Number Of Diluted Shares Outstanding | 443.4K | 31.8K | 1.5K | 1.4M | 878.4K | |||
| Earnings Per Share Basic | $-35.75 | $-466.89 | $-12,509.11 | $-11.22 | $-16.50 | |||
| Common Stock Shares Issued | 632.5K | 117.8K | 2.5K | 1.6M | 949.1K | 23.9M | 16.5M | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 26.4M | 16.6M | 13.6M | 10.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.76 | -$6.42 | -$1.58 | -$153.20 | -$4.0K | -$1.0K | -$54.14 | -$51.86 | -$2.59 | -$2.56 | -$2.67 | -$2.44 | -$0.14 | -$0.15 | -$0.15 | -$0.12 | -$0.15 | -$0.12 | -$0.05 | -$0.03 | -$0.02 | -$0.02 | |
| Common Stock Shares Authorized | 25.0M | 25.0M | 300.0M | 300.0M | 300.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Preferred Stock Shares Authorized | 416.7K | 416.7K | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 574.6K | 504.4K | 2.9M | 33.4M | 1.4M | 10.7M | 4.2M | 4.1M | 2.2M | 40.0M | 40.0M | 40.0M | 27.5M | 27.4M | 25.4M | 16.7M | 16.5M | 13.6M | 16.5M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 558.9K | 370.1K | 2.7M | 36.6K | 625.00 | 3.5K | 83.5K | 77.5K | 1.9M | 1.3M | 1.3M | 1.3M | 27.4M | 25.4M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 558.9K | 370.1K | 2.7M | 36.6K | 625.00 | 3.5K | 83.5K | 77.5K | 1.9M | 1.3M | 1.3M | 1.3M | 27.4M | 25.4M | |||||||||
| Earnings Per Share Basic | $-5.76 | $-6.42 | $-1.58 | $-153.20 | $-4,049.20 | $-1,020.48 | $-54.14 | $-51.86 | $-2.59 | $-2.56 | $-2.67 | $-2.44 | $-0.14 | $-0.15 | |||||||||
| Common Stock Shares Issued | 574.6K | 504.4K | 2.9M | 33.4M | 1.4M | 10.7M | 4.2M | 4.1M | 2.2M | 40.0M | 40.0M | 27.5M | 27.4M | 25.4M | 16.7M | 16.5M | 13.6M | 16.5M | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 27.4M | 25.4M | 24.7M | 16.5M | 16.5M | 16.5M | 13.6M | 13.2M | 12.7M | 10.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $187.7K | $839.0K | $1.0M | $1.2M | $1.3M | $477.1K | $102.7K | |
| Interest Paid Net | $15.3K | $13.6K | $13.8K | $8.1K | $9.8K | $1.7K | $4.0K | $0.00 |
| Depreciation | $3.9K | $3.3K | $4.1K | $11.8K | $13.1K | $11.1K | $2.0K | $0.00 |
| Additional Paid In Capital | $104.8M | $90.6M | $65.1M | $58.8M | $41.6M | $34.9M | $19.1M | $7.0M |
| Stock Issued During Period Value New Issues | $2.3M | $16.0M | $4.7M | $10.3M | $390.5K | |||
| Prepaid Expense Noncurrent | $503.0K | $36.4K | $104.8K | $482.8K | $929.7K | $0.00 | ||
| Prepaid Expense Current | $1.5M | $652.6K | $33.0K | |||||
| Stock Issued For Exercise Of Warrants | $2.7K | |||||||
| Interest Income Operating | $27.7K | $0.00 | ||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $3.6K | $21.3K | $3.0M | |||||
| Issuance Of Stock And Warrants For Services Or Claims | $596.3K | $0.00 | $0.00 | $150.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $18.5K | $21.8K | $62.4K | $271.8K | $234.3K | $202.9K | $194.8K | $289.7K | $290.3K | $289.7K | $286.8K | $336.7K | $365.0K | $323.2K | $242.2K | $172.9K | $69.8K | $44.0K | $44.0K | $9.5K | $5.2K | ||||
| Interest Paid Net | $6.2K | $6.6K | $5.4K | $2.9K | $4.2K | $0.00 | $0.00 | ||||||||||||||||||
| Depreciation | $1.1K | $818.00 | $1.3K | $3.4K | $3.0K | $1.9K | $0.00 | ||||||||||||||||||
| Additional Paid In Capital | $104.2M | $104.2M | $99.7M | $84.6M | $71.3M | $68.7M | $62.4M | $62.1M | $59.1M | $53.1M | $52.8M | $52.5M | $41.3M | $40.8M | $35.8M | $20.4M | $19.6M | $19.3M | $8.9M | ||||||
| Stock Issued During Period Value New Issues | $4.5M | $9.0M | $12.4M | $2.4M | $3.3M | $132.9K | $2.0M | $10.6M | $144.8K | $100.0K | $1.4M | $390.5K | |||||||||||||
| Prepaid Expense Noncurrent | $474.4K | $366.3K | $22.4K | $18.4K | $320.3K | $55.3K | $262.7K | $377.2K | $438.1K | $594.9K | $704.8K | $791.8K | |||||||||||||
| Prepaid Expense Current | $1.7M | $2.4M | $2.3M | $2.5M | $2.8M | $3.3M | $1.6M | $1.2M | $1.3M | $808.7K | $456.4K | ||||||||||||||
| Stock Issued For Exercise Of Warrants | $725.1K | $609.00 | $2.6K | $332.8K | |||||||||||||||||||||
| Interest Income Operating | $6.7K | $12.9K | $7.8K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $8.9K | $12.4K | $725.1K | $609.00 | |||||||||||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.